Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AveXis Data Reinforce Effectiveness of Zolgensma in Treating Spinal Muscular Atrophy (SMA) Type 1

drugsApril 18, 2019

Tag: AveXis , Zolgensma , CNS , sma , STR1VE

PharmaSources Customer Service